Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) issued an announcement. The group has obtained drug production registration approval from the China National Drug Administration for vitamin K1 injection (1ml: 10mg), which is a category 3 chemical drug, and is deemed to have passed the consistency evaluation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.